Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle

Virology

Volumn 312, Issue 1, 2003, Pages 245-253

  Nguyen, Hau ^a   Mudryj, Maria ^a,b   Guadalupe, Moraima ^a   Dandekar, Satya ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biphasic; cdk2; Cell cycle; Core protein; HCV; p21

Indexed keywords

CDK2 DEPENDENT KINASE; CORE PROTEIN; ENZYME; PROTEIN CDK INHIBITOR; PROTEIN INHIBITOR; PROTEIN P21; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL LINE; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; MODULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

HEPATITIS C VIRUS;

EID: 0042668538     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00209-5     Document Type: Article

References (40)

1. Aizaki H., Aoki Y., Harada T., Ishii K., Suzuki T., Nagamori S., Toda G., Matsuura Y., Miyamura T. Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample. Hepatology. 27:1998;621-627.
2. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2001;2764-2772.
3. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., Eder G., Schaff Z., Chapman M.J., Miyamura T., Brechot C. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA. 94:1997;1200-1205.
4. Chang J., Yang S.H., Cho Y.G., Hwang S.B., Hahn Y.S., Sung Y.C. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol. 72:1998;3060-3065.
5. Cho J., Baek W., Yang S., Chang J., Sung Y.C., Suh M. HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation. Biochim. Biophys. Acta. 1538:2001;59-66.
6. Cho J.W., Baek W.K., Suh S.I., Yang S.H., Chang J., Sung Y.C., Suh M.H. Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels. Liver. 21:2001;137-142.
7. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
8. Chuang L.S., Ian H.I., Koh T.W., Ng H.H., Xu G., Li B.F. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science. 277:1997;1996-2000.
9. Cook G., Campbell J.D., Carr C.E., Boyd K.S., Franklin I.M. Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes. J. Leukoc. Biol. 66:1999;981-988.
10. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., Wang X.F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;5545-5549.
11. Dotto G.P. p21(WAF1/Cip1) more than a break to the cell cycle? Biochim. Biophys. Acta. 1471:2000;M43-M56.
12. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
13. Harper J.W., Elledge S.J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:1996;56-64.
14. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
15. Jung E.Y., Lee M.N., Yang H.Y., Yu D., Jang K.L. The repressive activity of hepatitis C virus core protein on the transcription of p21 (waf1) is regulated by protein kinase A-mediated phosphorylation. Virus Res. 79:2001;109-115.
16. Kunkel M., Watowich S.J. Conformational changes accompanying self-assembly of the hepatitis C virus core protein. Virology. 294:2002;239-245.
17. Lee M.N., Jung E.Y., Kwun H.J., Jun H.K., Yu D.Y., Choi Y.H., Jang K.L. Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway. J. Gen. Virol. 83 (Pt 9):2002;2145-2151.
18. Li R., Waga S., Hannon G.J., Beach D., Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature. 371:1994;534-537.
19. Lo S.Y., Masiarz F., Hwang S.B., Lai M.M., Ou J.H. Differential subcellular localization of hepatitis C virus core gene products. Virology. 213:1995;455-461.
20. Lu W., Lo S.Y., Chen M., Wu K., Fung Y.K., Ou J.H. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology. 264:1999;134-141.
21. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4:1998;1065-1067.
22. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., Miyamura T., Koike K. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78 (Pt. 7):1997;1527-1531.
23. Ndolo T., Dhillon N.K., Nguyen H., Guadalupe M., Mudryj M., Dandekar S. Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycle. J. Virol. 76:2002;3587-3595.
24. Nelson D.R., Gonzalez-Peralta R.P., Qian K., Xu Y., Marousis C.G., Davis G.L., Lau J.Y. Transforming growth factor-beta 1 in chronic hepatitis C. J. Viral Hepat. 4:1997;29-35.
25. Otsuka M., Kato N., Lan K., Yoshida H., Kato J., Goto T., Shiratori Y., Omata M. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 275:2000;34122-34130.
26. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
27. Ray R.B., Lagging L.M., Meyer K., Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:1996;4438-4443.
28. Ray R.B., Lagging L.M., Meyer K., Steele R., Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:1995;209-220.
29. Ray R.B., Ray R. Hepatitis C virus core protein intriguing properties and functional relevance . FEMS Microbiol. Lett. 202:2001;149-156.
30. Ray R.B., Steele R., Meyer K., Ray R. Hepatitis C virus core protein represses 21WAF1/Cip1/Sid1 promoter activity. Gene. 208:1998;331-336.
31. Sabile A., Perlemuter G., Bono F., Kohara K., Demaugre F., Kohara M., Matsuura Y., Miyamura T., Brechot C., Barba G. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology. 30:1999;1064-1076.
32. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
33. Salvant B.S., Fortunato E.A., Spector D.H. Cell cycle dysregulation by human cytomegalovirus influence of the cell cycle phase at the time of infection and effects on cyclin transcription . J. Virol. 72:1998;3729-3741.
34. Suzuki R., Tamura K., Li J., Ishii K., Matsuura Y., Miyamura T., Suzuki T. Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus. Virology. 280:2001;301-309.
35. Uchida T. Pathology of hepatitis C. Intervirology. 37:1994;126-132.
36. Yamanaka T., Kodama T., Doi T. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem. Biophys. Res. Commun. 294:2002;528-534.
37. Yamanaka T., Uchida M., Doi T. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem. Biophys. Res. Commun. 294:2002;528-534.
38. Yasui K., Wakita T., Tsukiyama-Kohara K., Funahashi S.I., Ichikawa M., Kajita T., Moradpour D., Wands J.R., Kohara M. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72:1998;6048-6055.
39. Yoshida I., Oka K., Hidajat R., Nagano-Fujii M., Ishido S., Hotta H. Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein. Microbiol. Immunol. 45:2001;689-697.
40. Zhang H., Xiong Y., Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell. 4:1993;897-906.